NOVELIX
NOVELIX PHARMACEUTICALS LIMITEHealthcare
LTP
70.74
CHG · %
-2.98 (-4.04%)
VOL · TODAY
8.92K
PREV CLOSE
73.72
Today's range70.1 · 77
70.74
52-week range23 · 77
70.74
Loading candles…
Novelix Pharmaceuticals Ltd, incorporated in 1994 and headquartered in Hyderabad, operates in the pharmaceuticals and life sciences industries in India. Formerly known as Trimurthi Limited, the company underwent a strategic pivot and rebranding in late 2024 to concentrate exclusively on life sciences and pharmaceutical research sectors. Its business segments include the research, development, manufacturing, and trading of Active Pharmaceutical Ingredients (APIs), bulk drugs, pharmaceutical intermediates, key starting materials, and pharmaceutical-related products and securities. While the company does not have publicly disclosed founders, key management, subsidiaries, or listing exchanges, it maintains a presence through its varied pharmaceutical product offerings and trading activities.
NOVELIX is not part of any active scan today.
This page is a live market overview for NOVELIX PHARMACEUTICALS LIMITE (NOVELIX) on the BSE. As a listed security, NOVELIX PHARMACEUTICALS LIMITE is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NOVELIX before placing trades on tick2trade.
As of the latest feed, NOVELIX last traded at ₹70.74 on BSE, down ₹2.98 (4.04%) from the previous close of ₹73.72. Today's session range is ₹70.1 – ₹77, against a 52-week band of ₹23 – ₹77. Traded volume today stands at 8.92K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for NOVELIX in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NOVELIX is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NOVELIX PHARMACEUTICALS LIMITE before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NOVELIX. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NOVELIX option chain page linked from this overview.
// similar in healthcare314 total